NJOY Plans to Expand to 100,000 Stores by Year-End: FDA Approves First Menthol E-Cigarettes for US Sales
According to a report by CSPdaily News on June 26, it was revealed that NJOY, a subsidiary of Altria (Altria Group, Inc.), has expanded its sales network to over 80,000 retail stores in the first quarter of 2024. The company recently emphasized that they expect to "expand to approximately 100,000 retail stores by the end of the year.
NJOY continues to roll out its first retail trade program, aimed at helping the brand achieve optimal visibility and product placement in the retail market.
This expansion also comes with the U.S. Food and Drug Administration (FDA) granting marketing authorization to NJOY LLC for four menthol-flavored e-cigarette products, including NJOY ACE Pod Menthol 2.4%, NJOY ACE Pod Menthol 5%, NJOY DAILY Menthol 4.5%, and NJOY DAILY EXTRA Menthol 6%. This event marks the first time that the FDA has authorized non-tobacco flavored e-cigarette products.
NJOY CEO Shannon Leistra stated,
With the addition of NJOY menthol e-cigarette products, we now have a unique FDA-authorized product lineup to support adult smokers transitioning to smoke-free alternatives. We believe these marketing authorizations demonstrate the quality of NJOY products and the strength of evidence supporting the authorized NJOYmint e-cigarette products.
The senior vice president of regulatory affairs at the Aochiya Customer Service Company, Paige Magness, stated that...
The FDA has approved NJOY menthol-flavored e-cigarette product, providing a regulated alternative for adult smokers and e-cigarette users to replace the currently available illegal flavored disposable e-cigarette products on the market. We believe the marketing approval of NJOY mint is a positive outcome for public health.
Click on the text to continue reading:
Altria submits on! PLUS nicotine pouch PMTA application, covering three new flavors.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
